Setipiprant
Sponsors
Idorsia Pharmaceuticals Ltd., Allergan
Conditions
AlopeciaAsthma
Phase 2
Clinical Study to Explore the Efficacy of ACT-129968 in Patients With Partly Controlled Asthma
CompletedNCT01225315
Start: 2010-11-01End: 2012-02-01Updated: 2018-07-09
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
CompletedNCT02781311
Start: 2016-07-14End: 2018-05-22Updated: 2019-04-05